Exam 1 Flashcards
Cholinergic agonists - effects
Increase: salivation, GI motility, urination
Decrease: HR, BP
Constrict: pupils (miosis) and bronchioles
Dilate: blood vessels
Cholinergic agonists - why are they prescribed?
Glaucoma, urine retention, dry mouth, myasthenia gravis, Alzheimer’s disease
Cholinergic agonists - safe administration and relevant practice factors
For glaucoma eye drops - pinch nose to keep local
For adults - don’t drive
Older adults - increased risk of toxic levels, start low and go slow, beware of falling
Stay near toilet
At home: beware of tripping hazards and dim lights
Increased bleeding risk if taken with NSAIDs
Cholinergic agonists - medical related assessments
Measure heart rate to make sure it’s not too low before administering.
Look at I/O, baselines, allergies
Cholinergic agonists - therapeutic actions
Direct: stimulate nicotinic and muscarinic directly
Indirect: block acetylcholinerase, leading to accumulation of ACh
These both lead to a parasympathetic effect
Cholinergic agonists - timing and route
Orally on empty stomach (direct)
Indirect with meals
Galantamine: solution to swallow twice/day
Rivastigmine: solution to swallow twice/day or XR once/day
Donepezil: once/day rapidly dissolving tablet
Edrophonium: diagnostic agent for myasthenia gravis
IV slowly and keep Atropine close by
Cholinergic agonists - adverse effects
Diarrhea and vomiting, sweating, drowsiness, dizziness, urinary urgency
Cholinergic agonists - contraindications and cautions
Bradycardia, asthma, bowel or urinary obstruction, hypotension, allergy, peptic ulcer disease, epilepsy, Parkinsonism
Caution for pregnant and lactating
Anticholinergic agents - therapeutic actions
Block the effects of acetylcholine
Lyse/block effects of parasympathetic
This allows the sympathetic nervous system to kick in
Do not block nicotinic, only muscarinic
Anticholinergic agents - why are they prescribed?
Patient has bowel hyperactivity, antidote for Cholinergic OD (Atropine), overactive bladder, drooling, COPD to prevent bronchospasm, motion sickness
Anticholinergic agents - effects
Increase- HR, BP
Decrease- bowel and urine activity, salivation
Constrict- blood vessels, sphincter
Dilate- pupils (mydriasis)
Anticholinergic agents - safe administration and relevant practices
Keep hydrated and stay out of sun for long periods of time due to decreased sweating.
No driving.
Older adults: Start low go slow
Drink water, pee before, lozenges for dry mouth, increased fiber and exercise
At home beware of dim lights and tripping hazards
Anticholinergic agents - medical related assessments
Monitor vitals, check ECG, assess for disease that decreases bowel motility, neurological status, reflexes, papillary response, renal function labs
Anticholinergic agents - timing and route of administration
Take after peeing to help with urine retention
Anticholinergic agents - adverse effects
Blurred vision, cycloplegia, photophobia, palpitations, tachycardia, dry mouth, altered taste, constipation
“Can’t spit can’t see can’t poop can’t pee”
Anticholinergic agents - contraindications and cautions
Glaucoma, allergy, stenosing peptic ulcer disease, enlarged prostate, bladder or bowel obstruction
Caution with breastfeeding and brain damage
Dicyclomine
For bowel hyperactivity
Glycopyrrolate
For drooling
Ipratropium
For COPD to prevent bronchospasm
Meclizine
For motion sickness
Oxybutynin chloride
For overactive bladder
Scopolamine
For motion sickness
Tiotropium
For COPD bronchospasm
Tolterodine
For overactive bladder
Donepezil
For Alzheimer’s
Rivastigmine
For Alzheimer’s
Galantamine
For Alzheimer’s
Neostigmine
For myasthenia gravis
Pyridostigmine
For myasthenia gravis
Edrophonium
Diagnostic agent for myasthenia gravis
Bethanechol
For urinary retention
Carbachol
For glaucoma
Cevimeline
For dry mouth
Pilocarpine
For dry mouth
Cycloplegia
Inability to focus on objects up close
Belladonna
Plant from which Anticholinergic drugs come
Receptor(s) Anticholinergic block
Cholinergic receptors in sympathetic
Only muscarinic in parasympathetic
Not nicotinic
Stenosing
Narrowing
Cholinergic agonists, drug-drug
Acetylcholinerase - increases effects
NSAIDS increase bleeding
Other Cholinergic drugs increase effects
Anticholinergic drug-drug
Antihistamines, antiparkinsonian, MAOI, TCAs
Hyperglycemia >
126 mg/dL
Atherosclerosis
MI and strokes from plaque in vessels
Retinopathy
Vision loss from narrowing eye vessels
Neuropathy
Motor and sensory changes to nerves due to decreased oxygen;
Pain, numbness, tingling
Nephropathy
Renal dysfunction
Beta cells still work in
DM 2
Polyuria
Increased pee
Polydipsia
Increased thirst
Polyphagia
Increased hunger
Signs of dangerous hyperglycemia
Fruity breath
Dehydration
Kussmar’s respiration- slow, deep
Loss of orientation
Acting drunk
Hypoglycemia <
70 mg/dL
Signs of hypoglycemia
Shaking
Dizzy
Sweating
Hungry
Tachycardia
Decreased concentration
Confusion
Moody
Only DM oral for kids
Metformin
Garlic’s effect on blood sugar
Decreases
DM drug for pregnant/lactating
Insulin
Insulin actions
Stimulates glycogen synthesis
Drives glucose into cells
Lowers blood sugar
Insulin indications
DM 1 - replaces insulin due to damaged beta cells
DM 2 - when diet and exercise is not enough
Insulin contraindications
None!
Insulin adverse
Hypoglycemia from overdosing
Keto acidosis from underdosing
Insulin drug-drug
Beta blockers (for hyperT) mask hypoG effects
Insulin assessment
Physical, history, vitals
Urinalysis for sugar or ketones
Asthma, COPD, skin lesions, orientation, reflexes, consciousness
Diet, exercise, weight changes, footwear
Lab values - HbA1c for average blood sugar levels for last 3 months
Insulin diagnoses
Risk for unstable blood glucose
Imbalanced nutrition
Disturbed sensory perception
Risk for infection from injection
Risk for injury
Ineffective coping
Deficient knowledge
Insulin implementation
Diet and exercise
Introduce client to American Diabetic Association website
Gently rotate vial- don’t shake
Subcutaneous or inhaled
Teach: how and when to test glucose, when to seek medical help, F/Us, diary
Verify insulin name
2 nurse check
Administer with meal
Inspect feet
Store in dark dry place
Get family involved
Insulin evaluation
Stable glucose levels?
Complications?
Adverse effects?
Compliance?
Regular onset
30-60 minutes
Regular peak
2-4 hours
Regular duration
6-12 hr
NPH onset
60-90 minutes
NPH peak
4-12 hr
NPH duration
24 hr
Inhaled onset
12-15 minutes
Inhaled peak
60 minutes
Inhaled duration
2.5-3 hr
Lispro onset
< 15 minutes
Lispro peak
30-90 minutes